BioNexus Gene Lab (BGLC) EV to FCF (2021 - 2026)

BioNexus Gene Lab has disclosed EV to FCF across 6 years of filings, most recently posting 0.23 for Q2 2026.

• In Q2 2026, EV to FCF rose 89.47% year-over-year to 0.23; the TTM figure through Jun 2026 stood at 0.12 (up 78.16% YoY), while the FY2025 annual figure was 1.76, down 689.19% from the prior year.
• EV to FCF came in at 0.23 for Q2 2026 at BioNexus Gene Lab, down from 7.11 in the prior quarter.
• In the past five years, EV to FCF ranged from a high of 74830.84 in Q4 2022 to a low of 8866.04 in Q2 2023.
• Average EV to FCF over 5 years is 3369.24, with a median of 4.28 recorded in 2024.
• Year-over-year, EV to FCF soared 9842.76% in 2022 and tumbled 789.18% in 2023.
• Over 5 years, EV to FCF stood at 74830.84 in 2022, then tumbled by 100.01% to 6.0 in 2023, then jumped by 46.46% to 3.21 in 2024, then jumped by 206.73% to 3.43 in 2025, then sank by 106.82% to 0.23 in 2026.
• Per Business Quant data, the three most recent EV to FCF figures were 0.23 in Q2 2026, 7.11 in Q1 2026, and 3.43 in Q4 2025.